Old Web
English
Sign In
Acemap
>
authorDetail
>
Olivier Van de Steen
Olivier Van de Steen
Medicine
Intensive care medicine
Pediatrics
Disease
Ritonavir
3
Papers
123
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial
2018
The Lancet Respiratory Medicine
Toby M. Maher
Ellen Van der Aar
Olivier Van de Steen
Lisa Allamassey
Julie Desrivot
S. Dupont
Liesbeth Fagard
Paul Ford
Ann Fieuw
Wim Wuyts
Show All
Source
Cite
Save
Citations (112)
The Burden of Severe Respiratory Syncytial Virus Disease Among Children Younger than 1 Year in Central and Eastern Europe
2016
Infectious Diseases and Therapy
Olivier Van de Steen
Farzaneh Miri
Marta Gunjaca
Vanesa Klepac
Baerbel Gross
Gerard Notario
Colleen Wegzyn
Show All
Source
Cite
Save
Citations (10)
Cost-minimization comparison of darunavir plus ritonavir and lopinavir/ritonavir in HIV-1 infected treatment-naïve women of childbearing age
2014
Journal of Medical Economics
Jörgen Möller
Kamal Desai
Kit N. Simpson
Robert W. Baran
Olivier Van de Steen
Birgitta Dietz
Katherine Gooch
Show All
Source
Cite
Save
Citations (1)
1